根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$Isoray(ISR)$ PREM14A Preliminary proxy statements relating to merger or acquisition Accession Number: 0001437749-22-024694 Act: 34 Size: 7 MB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-22-024622 Act: 34 Size: 190 KB 网页链接
$Isoray(ISR)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-22-024623 Act: 34 Size: 49 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-22-024534 Act: 33 Size: 1 MB 网页链接
$Isoray(ISR)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-22-023188 Act: 34 Size: 7 MB 网页链接
$Isoray(ISR)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001437749-22-023176 Act: 34 Size: 329 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01, 3.02, 5.01, and 9.01 Accession Number: 0001437749-22-023177 Act: 34 Size: 1 MB 网页链接
$Isoray(ISR)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-22-023178 Act: 34 Size: 906 KB 网页链接
$Isoray(ISR)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-022927 Size: 7 KB 网页链接
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-021066 Size: 6 KB 网页链接